Table 1 |
|||
|
Characteristics of primary Sjögren's syndrome, nonprimary Sjögren's syndrome sicca and control subjects |
|||
|
Characteristic |
pSS (n = 24) |
Non-pSS sicca (n = 16) |
Controls (n = 25) |
|
|
|||
|
Age (years) |
49.0 ± 15.8 |
52.8 ± 15.4 |
59.0 ± 12.0 |
|
Female:male |
21:3 |
13:3 |
12:13 |
|
Ethnicity |
24 Caucasian |
16 Caucasian |
25 Caucasian |
|
Unstimulated whole saliva (ml/minute) |
0.10 ± 0.14 |
0.12 ± 0.18 |
NA |
|
Stimulated whole saliva (ml/minute) |
0.31 ± 0.35 |
0.33 ± 0.40 |
NA |
|
Schirmer's test (mm) |
9.2 ± 7.6 |
14.8 ± 11.7 |
NA |
|
Focal score |
3.5 ± 1.2 |
0.5 ± 1.0 |
0 |
|
Sjögren's syndrome - A (positive:negative) |
23:1 |
2:14 |
0:25 |
|
Sjögren's syndrome - B (positive:negative) |
19:5 |
0:16 |
0:25 |
|
|
|||
|
Data presented as the mean ± standard deviation. All primary Sjögren's syndrome (pSS) and non-pSS sicca patients were subjected to a complete American-European Consensus Group diagnostic work-up. NA, not assessed (in controls being head and neck cancer patients without parotid involvement, no functional tests were performed as all these patients were already scheduled for a neck dissection and functional tests were considered too much of a burden to the patients at that time). |
|||
|
Horvath et al. Arthritis Research & Therapy 2012 14:R238 doi:10.1186/ar4081 |
|||